NCT01721564View on ClinicalTrials.gov

Bosentan and Pulmonary Endothelial Function

NACompletedINTERVENTIONAL
Enrollment

8

Participants

Timeline

Start Date

April 30, 2006

Primary Completion Date

May 31, 2009

Study Completion Date

December 31, 2009

Conditions
Pulmonary Arterial Hypertension
Interventions
DRUG

Bosentan

62.5 mg Bosentan twice a day for 1 month 125 mg Bosentan twice a day for 5 months

All Listed Sponsors
lead

Prof David S Celermajer

OTHER

NCT01721564 - Bosentan and Pulmonary Endothelial Function | Biotech Hunter | Biotech Hunter